Clinician accuracy in identifying essential laryngeal landmarks on swallowing fluoroscopy.

Authors:
Zhao NW; MacDonald BV; Pietrowski JR; Laus J; Evangelista LM and 3 more

Journal:
Laryngoscope Investig Otolaryngol

Publication Year: 2023

DOI:
10.1002/lio2.1127

PMCID:
PMC10601579

PMID:
37899869

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Laryngoscope Investig Otolaryngol

Abbreviation: Laryngoscope Investig Otolaryngol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Otorhinolaryngology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
ACE2 and TAS2R38 receptor expression in pediatric and adult patients in the nasal and oral cavity.
Franks ZG; Nandakumar K; Santhanam L and 3 more (2024) - Transparency Score: 4/6
A comparative analysis of laryngeal nerve damage in patients with idiopathic vocal cord paralysis e…
Liu XH; Yan J; Li N and 8 more (2024) - Transparency Score: 3/6
A quantitative analysis of Twitter ("X") trends in the discussion of rhinoplasty.
Mandava S; Oyer SL; Park SS. (2024) - Transparency Score: 2/6
A response to a single cadaver study assessing the efficacy of two commercially available devices f…
Gould SJ. (2024) - Transparency Score: 3/6
Factors associated with successful electrolarynx use after total laryngectomy, a multi-institutiona…
Pan C; Andrews LIB; Johnson E and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT Clark A. Rosen reports the following disclosures and financial relationships: Olympus America Inc., consultant; Instrumentarium, royalties; Freudenberg Medical, consultant; Reflux Gourmet LCC, shareholder. Peter C. Belafsky reports the following disclosures and financial relationships: Reflux Gourmet, LLC, co‐founder; Hope Medical, co‐founder; California Institute of Regenerative Medicine, grant support; Innovio, grant support. The other authors have no financial relationships or conflicts of interest to disclose."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025